Tech Company Financing Transactions
EyeGate Pharmaceuticals Funding Round
Private investors participated in a $969 thousand capital raise for EyeGate Pharmaceuticals. The funding round was announced by the company on 9/30/2013.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Debt
Amount
$968,971
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
271 Waverley Oaks Rd. 108
Waltham, MA 02452
USA
Waltham, MA 02452
USA
Phone
Website
Email Address
Not Recorded
Overview
EyeGate Pharma (NASDAQ: EYEG) is a late-stage specialty pharmaceutical and drug delivery company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen From
Chief Financial Officer
Sarah Romano
VP - Engineering
Michael Manzo
VP - Operations
Lisa Brandano
VP - R & D
Brenda Mann
Browse more venture capital transactions:
Prev: 9/30/2013: NaZura BioHealth venture capital transaction
Next: 9/30/2013: Proxy Debt Buyer venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs